Cargando…
Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study
The emergency of the coronavirus disease 2019 (COVID-19) pandemic led to the off-label use of drugs without data on their toxicity profiles in patients with COVID-19, or on their concomitant use. Patients included in the COVID-19 Patient Registry of a tertiary hospital during the first wave were ana...
Autores principales: | Aguilera, Cristina, Danés, Immaculada, Guillén, Elena, Vimes, Alba, Bosch, Montserrat, Cereza, Gloria, Sánchez-Montalvá, Adrián, Campos-Varela, Isabel, Miarons, Marta, Mestre-Torres, Jaume, Agustí, Antònia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316110/ https://www.ncbi.nlm.nih.gov/pubmed/35885517 http://dx.doi.org/10.3390/diagnostics12071612 |
Ejemplares similares
-
Educational sessions in pharmacovigilance: What do the doctors think?
por: Vallano, Antonio, et al.
Publicado: (2010) -
Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2021) -
Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022) -
Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
por: Filippi-Arriaga, Francesca, et al.
Publicado: (2023) -
Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study
por: Aguilera, Cristina, et al.
Publicado: (2021)